B
CELG

BancorpSouth’s Celgene Corp CELG Stock Holding History

BancorpSouth’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$416K Buy
2,852
+83
+3% +$11.3K 0.04% 160
2017
Q2 		$360K Buy
+2,769
New +$339K 0.04% 156
2013
Q4 		– Sell
-7,812
Closed -$602K – 249
2013
Q3 		$602K Sell
7,812
-150
-2% -$10.5K 0.07% 107
2013
Q2 		$466K Buy
+7,962
New +$479K 0.06% 137

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BancorpSouth's CELG Position: Q3 2017 in Review

BancorpSouth increased its Celgene Corp (CELG) stake by 3% in Q3 2017, buying an estimated $11.3K and bringing the position to 2,852 shares worth $416K. The position accounts for 0.04% of the portfolio, ranked #160.

BancorpSouth first reported a position in CELG in Q2 2013 and has held it in 4 quarters since. The position peaked at $602K in Q3 2013. 1,484 funds tracked by Wall St. Rank hold CELG as of Q3 2017.

  • BancorpSouth held 2,852 shares of Celgene Corp worth $416K as of Q3 2017.
  • BancorpSouth bought 83 Celgene Corp shares in Q3 2017, an estimated $11.3K.
  • Celgene Corp made up 0.04% of BancorpSouth's portfolio in Q3 2017, its #160 holding.
  • BancorpSouth first reported a position in Celgene Corp in Q2 2013 and has held it in 4 quarters since.
  • BancorpSouth's Celgene Corp position peaked at $602K in Q3 2013.
  • 1,484 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2017.

Based on BancorpSouth's 13F filing for Q3 2017, filed 14 Nov 2017.